Treatment indications informed by a priori implant information

Patent №

US 8,409,132

Granted

2013-04-02

Filed 2007

Owner

SEARETE LLC

+1 more

Lab

AI components

1

planning

Assignment

Recorded

Dataset

AIPD

2023_r1 edition

Application

12005122

Systems and methods are described for implementing or deploying therapeutic administration systems for obtaining a flow-change-indicative measurement and signaling a decision whether to administer one or more clot-reducing agents at least partly based on the flow-change-indicative measurement.

PlanningA61M 39/24A61B 5/145A61M 5/14276G16H 20/17G16H 70/60A61M 31/00A61M 2005/1726A61M 2039/2413+5 more

AI classification

Planning0.85
Evolutionary computation0.01
Vision0.00
Knowledge representation0.00
Natural language0.00
AI hardware0.00
Speech0.00
Machine learning0.00

Ownership

SEARETE LLC

assignment · 207540927

THE INVENTION SCIENCE FUND I, LLC

assignment · 296710184

Assignors

FERREN, BRAN, HYDE, RODERICK A., ISHIKAWA, MURIEL Y., LEUTHARDT, ERIC C., RIVET, DENNIS J., WOOD, JR., LOWELL L., WOOD, VICTORIA Y.H.

On an employer assignment, the assignors are typically the inventors.

© 2026 NYSGPT2525 LLC